X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (364) 364
index medicus (362) 362
immunology (343) 343
animals (307) 307
mice (184) 184
dendritic cells (155) 155
t cells (151) 151
immunotherapy (146) 146
female (142) 142
antigens (133) 133
lymphocytes (116) 116
male (114) 114
t-lymphocytes - immunology (98) 98
article (81) 81
in-vivo (78) 78
medicine, research & experimental (78) 78
regulatory t-cells (75) 75
cancer (69) 69
oncology (68) 68
cd8-positive t-lymphocytes - immunology (65) 65
flow cytometry (65) 65
dendritic cells - immunology (64) 64
vaccination (64) 64
adult (63) 63
t-cells (63) 63
cd4-positive t-lymphocytes - immunology (61) 61
immunity (61) 61
antigen-specific t cells (59) 59
autoimmunity (59) 59
health aspects (59) 59
vaccines (59) 59
immune response (58) 58
research (57) 57
transplantation (57) 57
antigen-specific (55) 55
expression (55) 55
middle aged (55) 55
cell biology (53) 53
cells, cultured (53) 53
mice, inbred c57bl (53) 53
responses (53) 53
analysis (50) 50
lymphocytes t (50) 50
mice, inbred balb c (50) 50
peptides (50) 50
cytokines (49) 49
lymphocyte activation (49) 49
tolerance (49) 49
immune system (48) 48
t cell receptors (47) 47
t-lymphocytes, regulatory - immunology (47) 47
immune tolerance (46) 46
adoptive transfer (42) 42
induction (41) 41
antigen (40) 40
experimental autoimmune encephalomyelitis (39) 39
allergy and immunology (38) 38
antigen-specific tolerance (38) 38
biotechnology & applied microbiology (38) 38
antibodies (37) 37
immune-responses (37) 37
immunization (37) 37
review (37) 37
pharmacology & pharmacy (36) 36
vaccine (36) 36
b-lymphocytes - immunology (35) 35
care and treatment (35) 35
epitopes (35) 35
infection (35) 35
activation (34) 34
antigen-specific suppression (34) 34
antigens, neoplasm - immunology (34) 34
chemical and pharmacologic phenomena (34) 34
in-vitro (34) 34
aged (33) 33
antigen-specific cd8 (33) 33
antigen-specific immunotherapy (33) 33
differentiation (33) 33
mice, transgenic (33) 33
antigens - immunology (32) 32
autoimmune diseases (32) 32
immunologic memory (32) 32
immunotherapy - methods (32) 32
lymphocyte activation - immunology (32) 32
major histocompatibility complex (32) 32
cd4 (30) 30
hematology (30) 30
allergy (29) 29
disease (29) 29
multiple sclerosis (29) 29
physiological aspects (29) 29
t-lymphocytes - metabolism (29) 29
biochemistry & molecular biology (28) 28
cell proliferation (28) 28
medical research (28) 28
t-lymphocytes, cytotoxic - immunology (28) 28
cytokines - metabolism (27) 27
neoplasms - immunology (27) 27
neoplasms - therapy (27) 27
proteins (27) 27
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Scandinavian Journal of Immunology, ISSN 0300-9475, 01/2012, Volume 75, Issue 1, pp. 27 - 37
To control cervical cancer, efficient vaccination against human papillomavirus (HPV) is highly required. Despite the advantages and safety of the protein... 
SHOCK-PROTEIN GP96 | THERAPEUTIC VACCINE | FUSION-PROTEIN | CELLULAR-IMMUNITY | ISCOMATRIX(TM) ADJUVANT | PHYLOGENETIC CONSERVATION | N-TERMINAL FRAGMENT | ANTITUMOR IMMUNITY | IMMUNOLOGY | INTRAEPITHELIAL NEOPLASIA | ANTIGEN-SPECIFIC IMMUNOTHERAPY | Adjuvants, Immunologic - pharmacology | Viral Vaccines - pharmacology | Immunity, Humoral - immunology | Vaccines, Synthetic - pharmacology | Viral Vaccines - genetics | Papillomavirus E7 Proteins - immunology | Human papillomavirus 16 - immunology | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Papillomavirus E7 Proteins - genetics | Statistics, Nonparametric | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Disease Models, Animal | Glycoproteins - genetics | Immunization - methods | Mice, Inbred C57BL | Vaccines, Synthetic - genetics | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Immunity, Cellular - immunology | Glycoproteins - immunology | Animals | Papillomavirus Infections - prevention & control | Uterine Cervical Neoplasms - virology | Mice | Viral Vaccines - immunology | Antigens | Safety regulations | Peptides | Analysis | Vaccination | Heat shock proteins | Papillomavirus infections | Recombinant proteins | Cervical cancer | Protein binding | Animal models | Immune response | Helper cells | Adjuvants | Data processing | Glycoproteins | Lymphocytes T | Vaccines | E7 protein | Immunity | Immunogenicity | Splenocytes | Immunotherapy | gamma -Interferon | Fusion protein | Life Sciences | Vaccinology | Immunology
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 1 - 10
Journal Article
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 08/2017, Volume 12, pp. 6289 - 6301
The success of subunit vaccines has been hampered by the problems of weak or short-term immunity and the lack of availability of nontoxic, potent adjuvants. It... 
Draining lymph nodes | Ovalbumin | Antigen-specific humoral response | Adjuvant | Lycium barbarum polysaccharide liposome | antigen-specific humoral response | ACTIVATION | DENDRITIC CELLS | MACROPHAGES | VACCINE | NANOSCIENCE & NANOTECHNOLOGY | DELIVERY | NANOPARTICLES | RESPONSES | LIPOSOME | adjuvant | ovalbumin | II EXPRESSION | PHARMACOLOGY & PHARMACY | PROMOTE | draining lymph nodes | Adjuvants, Immunologic - administration & dosage | Adjuvants, Immunologic - pharmacology | Nanoparticles - chemistry | Ovalbumin - immunology | Immunity, Humoral - immunology | Dendritic Cells - immunology | CD4-Positive T-Lymphocytes - immunology | Immunity, Cellular - drug effects | Dendritic Cells - drug effects | Drugs, Chinese Herbal - administration & dosage | Ovalbumin - chemistry | Phospholipids - chemistry | Vaccines - immunology | Soybeans - chemistry | Liposomes - chemistry | Animals | Ovalbumin - pharmacokinetics | Drugs, Chinese Herbal - chemistry | CD8-Positive T-Lymphocytes - drug effects | Immunity, Humoral - drug effects | Antigens - immunology | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | CD8-Positive T-Lymphocytes - immunology | Vaccines - administration & dosage | Drug Delivery Systems - methods | CD4-Positive T-Lymphocytes - drug effects | Nanoparticles | Polysaccharides | Composition | Vaccination | Innovations | Liposomes | Chemical properties | Health aspects | Goji berries | Antigens | Lymphatic system | Dendritic cells | Cytokines | Lipids | Vaccines | FDA approval | Veterinary medicine | Cholesterol | Biomedical materials | Lymphocytes | Immunotherapy | Laboratory animals
Journal Article
OncoImmunology, ISSN 2162-4011, 10/2015, Volume 4, Issue 10, p. e1042199
Local immune-activating therapies seek to improve the presentation of tumor antigen, thereby promoting the activation of antitumor CD8(+) T cells and delaying... 
regulatory T cells | monosodium urate crystals | poly I:C | tumor immunotherapy | CD4 + T cells | IL-1β | mycobacteria | PD-1 | DENDRITIC CELLS | IL-1 beta | ANTIGEN-SPECIFIC EFFECTOR | INDUCTION | IMMUNOLOGY | IL-1 ACTS | RESPONSES | ENHANCE | ONCOLOGY | IMMUNOTHERAPY | EXPANSION | CD4(+) T cells | EXPRESSION | LYMPHOCYTES
Journal Article
by Khanniche, A and Zhou, L and Jiang, B and Song, J and Jin, YH and Yin, J and Wang, SJ and Ji, P and Shen, H and Wang, Y and Xu, HJ
FRONTIERS IN IMMUNOLOGY, ISSN 1664-3224, 04/2019, Volume 10, p. 887
TNF alpha inhibitors have shaped the landscape of rheumatoid arthritis (RA) therapy with high clinical efficiency. However, their impact on T cell recall... 
GOLIMUMAB | ANTIBODY | PERIPHERAL-BLOOD | CYTOKINE | ANKYLOSING-SPONDYLITIS | IMMUNOLOGY | rheumatoid arthritis | memory T cells | immune regulation | EFFECTOR | TUMOR-NECROSIS-FACTOR | DOUBLE-BLIND | TNF alpha inhibitor | DIFFERENTIATION | antigen specific | LYMPHOCYTES | TNFα inhibitor
Journal Article